Published date: 18 November 2021
Awarded contract - This means that the contract has been awarded to a supplier.
Contract summary
Industry
Pharmaceutical products - 33600000
Location of contract
SW1H 0EU
Value of contract
£1
Procurement reference
CF-0475000D0O000000rwimUAA2
Published date
18 November 2021
Closing date
17 October 2021
Closing time
11pm
Contract start date
18 October 2021
Contract end date
31 December 2022
Contract type
Supply contract
Procedure type
Negotiated procedure without prior publication (above threshold)
The opportunity was not advertised, because for example only one supplier is capable of delivering the requirement, or due to extreme urgency brought about by unforeseen events.
This procedure can be used for procurements above the relevant contract value threshold.
Contract is suitable for SMEs?
No
Contract is suitable for VCSEs?
No
Description
Vaccines have been shown to be highly effective in the fight against COVID-19, to date. However, there is a cohort of individuals who either cannot take the vaccine or for whom it is ineffective. There is therefore an urgent need to find an effective alternative. So far there are no primary care antiviral drugs that can be easily dispensed specifically to treat SARS-CoV-2 and prevent its transmission in the community.
This agreement is for the procurement of 250,000 units of PF-07321332/ritonavir . It is one of the first oral and direct-acting antiviral drugs globally and is part of the UK's multi-layered approach to COVID-19.
More information
Previous notice about this procurement
PF-07321332 Supply Agreement for Pandemic Purposes
- Awarded contract
- Published 17 November 2021
Links
-
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Gxiw/3yJDWj5udj7FO4tzDfhNdXwWE5drgWONk7TzsS8B7HA
- FINAL - Antiviral Supply Agreement Redacted Version 171121_Redacted
Award information
Awarded date
18 October 2021
Contract start date
18 October 2021
Contract end date
31 December 2022
Total value of contract
£1
This contract was awarded to 1 supplier.
Pfizer Limited
Address
Walton Oaks, Dorking Road KT20 7NS
Reference
None
Supplier is SME?
No
Supplier is VCSE?
No
About the buyer
Contact name
Amy Watkins
Address
39 Victoria Street
London
SW1H 0EU
GB
Share this notice
Closing: 17 October 2021, 11pm